Senior insider sale
Chief Executive Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$814.8K
33.17K shares
What this filing means
ACCARDI MARIO ALBERTO plans to sell 33.17K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $814.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/8/2025ACC: 0001969223-25-001049
DirectorOfficer· Chief Executive Officer
Since Feb 2026
33.17K
Shares to sell
$814.8K
Approx. market value
10K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Exercise of stock options
Cash
12/8/2025
5KFounders Shares
NA
1/2/2020
5KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/8/2025 | Exercise of stock options Cash | 5K | — |
1/2/2020 | Founders Shares NA | 5K | — |
| Total | 10K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
8K
Market value
$200.0K
10/27/2025
—Completed
Units to sell
8.17K
Market value
$174.8K
9/16/2025
—Completed
Units to sell
7K
Market value
$140.0K
9/9/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
10K
Market value
$300.0K
12/8/2025
Total
Units
33.17K
Value
$814.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/27/2025 | 8K | $200.0K | — | Completed |
9/16/2025 | 8.17K | $174.8K | — | Completed |
9/9/2025 | 7K | $140.0K | — | Completed |
| Planned — Approximate Date | ||||
12/8/2025 | 10K | $300.0K | Nasdaq | Planned |
| Total | 33.17K | $814.8K | ||